awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38037672-032C624B-9456-4B03-8E13-34BC32706068
Q38037672-032C624B-9456-4B03-8E13-34BC32706068
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38037672-032C624B-9456-4B03-8E13-34BC32706068
Appropriate anti-thrombotic/anti-thrombin therapy for thrombotic lesions.
P2860
Q38037672-032C624B-9456-4B03-8E13-34BC32706068
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38037672-032C624B-9456-4B03-8E13-34BC32706068
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dd6368a8eb0e2d5ab24bcea20fc929e5ef29fdf3
P2860
Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial.